Search research articles
Contact Us
Filters
Showing results (61-70 of 126) with videos related to
Page
of 13
Sort By:
Cell Proliferation
|
February 27, 2023
Activation of ERK1/2 by MOS and TPL2 leads to dasatinib resistance in chronic myeloid leukaemia cells
Masanobu Tsubaki, Tomoya Takeda, Yuuichi Koumoto, et al.
BMC Complementary Medicine and Therapies
|
March 16, 2020
Dasatinib reverses drug resistance by downregulating MDR1 and Survivin in Burkitt lymphoma cells
Mitsuki Tabata, Masanobu Tsubaki, Tomoya Takeda, et al.
Cytokine
|
February 5, 2011
Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma
Masanobu Tsubaki, Yuzuru Yamazoe, Masashi Yanae, et al.
Medical Oncology (Northwood, London, England)
|
June 17, 2025
Overexpression of miR-29a and miR-29b is involved in imatinib resistance via abrogated NF1 expression and increased ERK1/2 activation in chronic myeloid leukemia cells
Masanobu Tsubaki, Teruki Obana, Taira Matsuo, et al.
American Journal of Translational Research
|
September 24, 2015
Mangiferin suppresses CIA by suppressing the expression of TNF-α, IL-6, IL-1β, and RANKL through inhibiting the activation of NF-κB and ERK1/2
Masanobu Tsubaki, Tomoya Takeda, Toshiki Kino, et al.
BMB Reports
|
October 4, 2022
Hypoxia-inducible factor 1α inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells
Masanobu Tsubaki, Tomoya Takeda, Takuya Matsuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
July 14, 2012
[A survey of the dosage of zoledronic acid and investigation of the relationship between renal function and adverse events]
Masashi Yanae, Mariko Nakao, Kimiko Fujiwara, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 27, 2018
Tamoxifen suppresses paclitaxel-, vincristine-, and bortezomib-induced neuropathy via inhibition of the protein kinase C/extracellular signal-regulated kinase pathway
Masanobu Tsubaki, Tomoya Takeda, Mikihiro Matsumoto, et al.
Cancer Cell International
|
April 18, 2023
Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy
Masanobu Tsubaki, Tomoya Takeda, Takuya Matsuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 30, 2013
[A search for the risk factors for hiccups and evaluation of antiemetic therapy in CDDP-based chemotherapy, using cluster analysis]
Hajime Asano, Mizuki Watanabe, Akinori Kawaguchi, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 126) with videos related to
Sort By:
Page
of 13
Cell Proliferation
|
February 27, 2023
Activation of ERK1/2 by MOS and TPL2 leads to dasatinib resistance in chronic myeloid leukaemia cells
Masanobu Tsubaki, Tomoya Takeda, Yuuichi Koumoto, et al.
BMC Complementary Medicine and Therapies
|
March 16, 2020
Dasatinib reverses drug resistance by downregulating MDR1 and Survivin in Burkitt lymphoma cells
Mitsuki Tabata, Masanobu Tsubaki, Tomoya Takeda, et al.
Cytokine
|
February 5, 2011
Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma
Masanobu Tsubaki, Yuzuru Yamazoe, Masashi Yanae, et al.
Medical Oncology (Northwood, London, England)
|
June 17, 2025
Overexpression of miR-29a and miR-29b is involved in imatinib resistance via abrogated NF1 expression and increased ERK1/2 activation in chronic myeloid leukemia cells
Masanobu Tsubaki, Teruki Obana, Taira Matsuo, et al.
American Journal of Translational Research
|
September 24, 2015
Mangiferin suppresses CIA by suppressing the expression of TNF-α, IL-6, IL-1β, and RANKL through inhibiting the activation of NF-κB and ERK1/2
Masanobu Tsubaki, Tomoya Takeda, Toshiki Kino, et al.
BMB Reports
|
October 4, 2022
Hypoxia-inducible factor 1α inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells
Masanobu Tsubaki, Tomoya Takeda, Takuya Matsuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
July 14, 2012
[A survey of the dosage of zoledronic acid and investigation of the relationship between renal function and adverse events]
Masashi Yanae, Mariko Nakao, Kimiko Fujiwara, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 27, 2018
Tamoxifen suppresses paclitaxel-, vincristine-, and bortezomib-induced neuropathy via inhibition of the protein kinase C/extracellular signal-regulated kinase pathway
Masanobu Tsubaki, Tomoya Takeda, Mikihiro Matsumoto, et al.
Cancer Cell International
|
April 18, 2023
Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy
Masanobu Tsubaki, Tomoya Takeda, Takuya Matsuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 30, 2013
[A search for the risk factors for hiccups and evaluation of antiemetic therapy in CDDP-based chemotherapy, using cluster analysis]
Hajime Asano, Mizuki Watanabe, Akinori Kawaguchi, et al.
Page
of 13